
Dave Ricks steered the 150-year-old drug giant to a $1 trillion market cap. Can he defeat pharma’s boom-and-bust cycle? By Madison Muller and Brad StoneSee omnystudio.com/listener for privacy information.
Podzilla Summary coming soon
Sign up to get notified when the full AI-powered summary is ready.
Free forever for up to 3 podcasts. No credit card required.
Free AI-powered recaps of Listen to the Story and your other favorite podcasts, delivered to your inbox.
Free forever for up to 3 podcasts. No credit card required.